Posts tagged birth control and contraception

In episodes 106 and 107 of Bioethics on Air, “Changing the Messaging and Mechanisms of Plan B,” Joe Zalot interviews John Brehany, director of institutional relations at The National Catholic Bioethics Center, regarding the revised messaging for Plan B, which was published by the US Food and Drug Administration (FDA) on December 23, 2022 and stated that the medication “will not affect an existing pregnancy.” Brehany explains that this label change may be premature and elaborates on the moral challenge that will result from this revision.

Phil CerroniMarch 6, 2023beginning-of-life issues, birth control and contraception, catholic health care

Opill Threatens to Slip into Vulnerable Hands

The US Food and Drug Administration (FDA) plans to discuss the application submitted by French pharmaceutical company HRA Pharma for a new nonprescription drug called Opill in a public meeting soon. Opill is an oral progestin-only contraceptive. According to a public comment submitted to the FDA on November 14 and cosigned by The National Catholic Bioethics Center (NCBC), nonprescription contraceptives place women at disproportionate risk of adverse side effects. Moreover, this risk would affect especially adolescent women, who are recognized as a vulnerable population.

Vivian TorkDecember 19, 2022birth control and contraception